Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 31 peer-reviewed journal articles Updated
Neurology

Recognizing the Symptoms and Warning Signs

At a Glance

Autoimmune limbic encephalitis (ALE) causes a rapid onset of short-term memory loss, new psychiatric changes, and seizures over just a few weeks to months. This rapid timeline is a critical red flag that distinguishes ALE from slower conditions like Alzheimer's and requires urgent medical care.

Autoimmune limbic encephalitis (ALE) is a condition where the body’s immune system mistakenly attacks the limbic system, the part of the brain responsible for memory, emotions, and basic survival instincts [1][2]. Unlike many other brain conditions, ALE often appears suddenly and progresses rapidly, making early recognition of its warning signs critical for effective treatment [3][4].

The Speed of Symptoms: “Subacute” vs. Chronic

One of the most important clues to identifying ALE is how fast symptoms appear. Doctors describe the onset of ALE as subacute, meaning symptoms develop over a period of weeks to a few months [5][6].

This is a major “red flag” that distinguishes ALE from neurodegenerative diseases like Alzheimer’s. In Alzheimer’s, memory loss is typically chronic, progressing slowly over many years [7][8]. If a person goes from being fully functional to having significant memory or behavioral problems in just one or two months, doctors should immediately investigate for an autoimmune cause [9][3].

Core Warning Signs

While everyone’s experience is different, three main categories of symptoms often appear together in ALE:

  • Rapid Memory Loss: The most common sign is a sudden inability to form new memories. This often involves accelerated long-term forgetting, where a person can remember something for a few minutes but forgets it entirely an hour later [2][10].
  • Psychiatric Changes: Many patients experience “new-onset” psychiatric symptoms. This can include sudden emotional instability (mood swings), depression, paranoid thoughts, or even hallucinations [2][11][12]. Because these symptoms appear so quickly, they are often mistaken for a primary psychiatric illness [13][14].
  • Seizures: New-onset seizures are a hallmark of ALE. These often originate in the temporal lobe, the brain region involved in processing sensory input and emotions [15][16].

Antibody-Specific “Red Flags”

In some cases, the specific antibody causing the attack creates unique symptoms that can help doctors identify the condition faster.

LGI1 Antibodies

If the body is producing LGI1 antibodies, a very specific type of seizure called faciobrachial dystonic seizures (FBDS) often occurs [17][18].

  • What they look like: These are very brief (usually lasting only a few seconds), frequent jerks of the face, arm, or leg [19][20].
  • Why they matter: They often happen dozens of times a day and frequently serve as a “warning sign” that appears before the major memory loss begins [17][21].
  • Other signs: About 60% of people with LGI1 antibodies also have hyponatremia, which is a dangerously low level of sodium in the blood [22][23].

CASPR2 and GAD65 Antibodies

  • CASPR2: This can cause a mix of brain symptoms and nerve issues, such as neuromyotonia (involuntary muscle twitching or stiffness) and neuropathic pain [24][25].
  • GAD65: This type is often linked to very difficult-to-control temporal lobe epilepsy [26][27].

Anti-NMDAR Encephalitis: A Special Case

While Anti-NMDAR encephalitis often begins with the same limbic symptoms (memory loss and psychiatric changes), it is crucial to note that it typically progresses into a more diffuse, severe syndrome [28][29]. Patients may develop severe movement disorders (dyskinesias), breathing difficulties (hypoventilation), and unstable blood pressure [30]. Anti-NMDAR has its own distinct diagnostic criteria because it often affects the whole body, not just the limbic system.

When to Seek Urgent Evaluation

Because early treatment with immunotherapy (treatments that calm the immune system) is the best way to prevent permanent brain damage, any “subacute” decline in memory or behavior should be treated as a medical priority [31][3]. If symptoms include the sudden onset of seizures or the unique face/arm jerks mentioned above, a specialized neurological evaluation is necessary [15][17].

Common questions in this guide

How quickly do symptoms of autoimmune limbic encephalitis appear?
Symptoms of ALE usually develop subacutely, meaning they appear rapidly over a few weeks to a couple of months. This fast onset is a major clue that distinguishes it from slower-progressing neurodegenerative conditions like Alzheimer's disease.
What are the first warning signs of autoimmune limbic encephalitis?
The primary warning signs include sudden, rapid short-term memory loss, new psychiatric changes like severe mood swings or paranoia, and the onset of new seizures.
What do faciobrachial dystonic seizures look like?
These are very brief, frequent jerking movements of the face, arm, or leg that typically last only a few seconds. They are a specific warning sign often associated with LGI1 antibodies and can happen dozens of times a day before major memory loss begins.
Can autoimmune limbic encephalitis cause psychiatric problems?
Yes, sudden emotional instability, depression, paranoia, and even hallucinations are common. Because they appear so quickly, these neurological symptoms are sometimes initially mistaken for a primary psychiatric illness.
Why is my doctor checking my sodium levels for memory loss?
Dangerously low sodium levels, a condition known as hyponatremia, are found in about 60% of people with LGI1 antibodies. This blood test helps doctors identify if a specific autoimmune issue is causing the memory and behavior changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was the exact timeline of my symptoms, and does this qualify as 'subacute' onset?
  2. 2.If my symptoms include brief face or arm jerks, could these be faciobrachial dystonic seizures associated with LGI1 antibodies?
  3. 3.How does my memory loss profile compare to typical Alzheimer's disease?
  4. 4.Have you checked my blood sodium levels, and what do they indicate regarding a potential autoimmune cause?
  5. 5.Is my psychiatric presentation—like sudden mood changes or paranoia—consistent with limbic encephalitis?
  6. 6.Should we perform an EEG or MRI specifically looking for signals in the temporal lobes?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (31)
  1. 1

    Autoimmune encephalitis: what the radiologist needs to know.

    Sanvito F, Pichiecchio A, Paoletti M, et al.

    Neuroradiology 2024; (66(5)):653-675 doi:10.1007/s00234-024-03318-x.

    PMID: 38507081
  2. 2

    Neuropsychological Performance in Autoimmune Limbic Encephalitis: Evidence from an Immunotherapy-Naïve Cohort.

    Mueller C, Langenbruch L, Rau JMH, et al.

    Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists 2022; (37(4)):738-752 doi:10.1093/arclin/acac001.

    PMID: 35136904
  3. 3

    Diagnosing autoimmune limbic encephalitis.

    Budhram A, Leung A, Nicolle MW, Burneo JG

    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2019; (191(19)):E529-E534 doi:10.1503/cmaj.181548.

    PMID: 31085562
  4. 4

    [Auto-immune encephalitis in psychiatric practice].

    de Witte L, Kromkamp M, Schoenmaker N, et al.

    Tijdschrift voor psychiatrie 2015; (57(6)):446-51.

    PMID: 26073839
  5. 5

    Inpatient Management of Encephalopathy.

    Reddy P, Culpepper K

    Cureus 2022; (14(2)):e22102 doi:10.7759/cureus.22102.

    PMID: 35291547
  6. 6

    Three cases of antibody-LGI1 limbic encephalitis and review of literature.

    Bing-Lei W, Jia-Hua Z, Yan L, et al.

    The International journal of neuroscience 2019; (129(7)):642-648 doi:10.1080/00207454.2018.1512985.

    PMID: 30112956
  7. 7

    Autoimmune Encephalitis Resembling Dementia Syndromes.

    Bastiaansen AEM, van Steenhoven RW, de Bruijn MAAM, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2021; (8(5)) doi:10.1212/NXI.0000000000001039.

    PMID: 34341093
  8. 8

    Case Report/Case Series: Rare case of anti-LGI1 limbic encephalitis with rapidly progressive dementia, psychiatric symptoms, and frequently seizures: A case report.

    Wu H, Mei F, Liu L, et al.

    Medicine 2021; (100(29)):e26654 doi:10.1097/MD.0000000000026654.

    PMID: 34398024
  9. 9

    Anti-AMPA receptor encephalitis associated with Medullary thyroid cancer.

    Samad N, Wong J

    BMJ case reports 2018; (2018()) doi:10.1136/bcr-2018-225745.

    PMID: 30150348
  10. 10

    Loss of Autonoetic Awareness of Recent Autobiographical Episodes and Accelerated Long-Term Forgetting in a Patient with Previously Unrecognized Glutamic Acid Decarboxylase Antibody Related Limbic Encephalitis.

    Witt JA, Vogt VL, Widman G, et al.

    Frontiers in neurology 2015; (6()):130 doi:10.3389/fneur.2015.00130.

    PMID: 26106363
  11. 11

    Gastaut-Geschwind Syndrome, Faciobrachial Dystonic Seizure, and Autoimmune Limbic Encephalitis.

    Benhamou OJ, Tavakkoli M, Okan H, Nobler M

    Case reports in psychiatry 2018; (2018()):3835819 doi:10.1155/2018/3835819.

    PMID: 30631627
  12. 12

    Subjective psychiatric symptoms in post-acute autoimmune encephalitis: findings from the Australian autoimmune encephalitis consortium.

    Ko KY, Kazzi C, Seery N, et al.

    Journal of neurology 2025; (272(10)):665 doi:10.1007/s00415-025-13353-0.

    PMID: 41021036
  13. 13

    Clinical characterization of autoimmune encephalitis and psychosis.

    Hao Q, Wang D, Guo L, Zhang B

    Comprehensive psychiatry 2017; (74()):9-14 doi:10.1016/j.comppsych.2016.12.006.

    PMID: 28081431
  14. 14

    PSYCHIATRIC DISORDERS IN AUTOIMMUNE ENCEPHALITIS - LITERATURE REVIEW.

    Wcisło S, Bojkowska-Otrębska K, Łabuz-Roszak B

    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 2023; (51(5)):563-568 doi:10.36740/Merkur202305117.

    PMID: 38069859
  15. 15

    Clonal hematopoiesis in LGI1-antibody encephalitis.

    Shin SJ, Jang Y, Ahn SH, et al.

    Annals of clinical and translational neurology 2024; (11(10)):2785-2791 doi:10.1002/acn3.52192.

    PMID: 39199016
  16. 16

    Efficacy of rituximab on seizure control and cognitive symptoms in leucine-rich, glioma-inactivated 1 (LGI1) limbic encephalitis: a high-density electroencephalography case study.

    Cheli M, Dinoto A, Tommasini V, et al.

    Epileptic disorders : international epilepsy journal with videotape 2020; (22(5)):678-682 doi:10.1684/epd.2020.1213.

    PMID: 33146142
  17. 17

    Anti-LGI1 encephalitis: clinical presentation, imaging features, and prognostic analysis.

    Chen X, Liu Q, Wang X, et al.

    Frontiers in neurology 2025; (16()):1703647 doi:10.3389/fneur.2025.1703647.

    PMID: 41473232
  18. 18

    The exploration of the spectrum of motor manifestations of anti-LGI1 encephalitis beyond FBDS.

    Liu X, Han Y, Yang L, et al.

    Seizure 2020; (76()):22-27 doi:10.1016/j.seizure.2019.12.023.

    PMID: 31972532
  19. 19

    Faciobrachial motor seizures: A more apt description?

    Muthusamy S, Foroush NC, Seneviratne U

    Epilepsy & behavior reports 2021; (16()):100476 doi:10.1016/j.ebr.2021.100476.

    PMID: 34505053
  20. 20

    Leucine-Rich Glioma-Inactivated 1 Encephalitis: Broadening the Sphere.

    Rachdi A, Dupouy J, Benaiteau M, et al.

    Tremor and other hyperkinetic movements (New York, N.Y.) 2019; (9()) doi:10.7916/tohm.v0.663.

    PMID: 31656690
  21. 21

    Clinical diagnosis of LGI1 antibody encephalitis in an 83-year-old woman.

    Attwood JE, Naseer S, Michael S, Riley J

    BMJ case reports 2021; (14(1)) doi:10.1136/bcr-2020-237398.

    PMID: 33431450
  22. 22

    Autoimmune encephalitis with LGI1 antibodies: a report of two cases.

    Gawda A, Roszak M, Sierakowska A, et al.

    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 2025; (53(6)):816-820 doi:10.36740/Merkur202506116.

    PMID: 41554079
  23. 23

    Clinical features of limbic encephalitis with LGI1 antibody.

    Wang M, Cao X, Liu Q, et al.

    Neuropsychiatric disease and treatment 2017; (13()):1589-1596 doi:10.2147/NDT.S136723.

    PMID: 28670128
  24. 24

    Early-Stage Contactin-Associated Protein-like 2 Limbic Encephalitis: Clues for Diagnosis.

    Benoit J, Muñiz-Castrillo S, Vogrig A, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2023; (10(1)) doi:10.1212/NXI.0000000000200041.

    PMID: 36288995
  25. 25

    Autoimmune neuromyotonia.

    Comperat L, Pegat A, Honnorat J, Joubert B

    Current opinion in neurology 2022; (35(5)):597-603 doi:10.1097/WCO.0000000000001104.

    PMID: 35989569
  26. 26

    The limbic and extra-limbic encephalitis associated with glutamic acid decarboxylase (GAD)-65 antibodies: an observational study.

    Kuang Z, Baizabal-Carvallo JF, Alonso-Juarez M, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2025; (46(6)):2765-2777 doi:10.1007/s10072-024-07933-7.

    PMID: 39704979
  27. 27

    Temporal lobe epilepsy with GAD antibodies: neurons killed by T cells not by complement membrane attack complex.

    Tröscher AR, Mair KM, Verdú de Juan L, et al.

    Brain : a journal of neurology 2023; (146(4)):1436-1452 doi:10.1093/brain/awac404.

    PMID: 36314080
  28. 28

    Botulinum toxin treatment for hypersalivation in anti-NMDA receptor encephalitis.

    Jun JS, Seo HG, Lee ST, et al.

    Annals of clinical and translational neurology 2017; (4(11)):830-834 doi:10.1002/acn3.467.

    PMID: 29159196
  29. 29

    Clinical Spectrum of Encephalitis Associated With Antibodies Against the α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor: Case Series and Review of the Literature.

    Joubert B, Kerschen P, Zekeridou A, et al.

    JAMA neurology 2015; (72(10)):1163-9 doi:10.1001/jamaneurol.2015.1715.

    PMID: 26280228
  30. 30

    Diagnosis and Clinical Features in Autoimmune-Mediated Movement Disorders.

    Hsieh PC, Wu YR

    Journal of movement disorders 2022; (15(2)):95-105 doi:10.14802/jmd.21077.

    PMID: 35670020
  31. 31

    Anti-LGI1 Autoimmune Limbic Encephalitis: An Easy-To-Miss Diagnosis.

    Freitas Henriques C, Fernandes R, Neves L, et al.

    European journal of case reports in internal medicine 2024; (11(12)):005025 doi:10.12890/2024_005025.

    PMID: 39651393

This page provides educational information about the symptoms of autoimmune limbic encephalitis. It is not a substitute for professional medical advice, and any sudden memory or behavioral changes require immediate emergency evaluation by a neurologist.

Get notified when new evidence is published on Autoimmune limbic encephalitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.